Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fyfe

Showing results (851-860 of 1,174) with videos related to

Pageof 118
Sort By:
European Journal of Preventive Cardiology|October 4, 2024
Cardiorespiratory Fitness in Childhood Cancer Survivors: A Systematic Review and Meta-AnalysisKaitlyn Weinkauf, Emma Fyfe, Dean Hewitt, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
<i>In Vitro</i> Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017Ian Morrissey, Stephen Hawser, Sibylle H Lob, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 8, 2022
Asymmetric Synthesis of Heterocyclic Chloroamines and Aziridines by Enantioselective Protonation of Catalytically Generated EnaminesLiam A McLean, Matthew W Ashford, James W B Fyfe, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 18, 2006
Expression and function of potassium channels in the human placental vasculatureMark Wareing, Xilian Bai, Fella Seghier, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibioticTrudy H Grossman, Agata L Starosta, Corey Fyfe, et al.
Investigational New Drugs|May 1, 1993
Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinomaR M Bukowski, J Young, G Goodman, et al.
Virology|March 12, 2002
Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapyJoseph Torresi, Linda Earnest-Silveira, Georgia Deliyannis, et al.
Thrombosis and Haemostasis|July 1, 1997
Tissue factor in the pathogenesis of atherosclerosisM B Taubman, J T Fallon, A D Schecter, et al.
Gut|February 24, 2007
Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori statusSvein Hansen, Stein Emil Vollset, Mohammad H Derakhshan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
A phase I and pharmacokinetic study of ixabepilone in combination with Carboplatin in patients with advanced solid malignanciesRuth Plummer, Penella Woll, David Fyfe, et al.
Pageof 118

Showing results (851-860 of 1,174) with videos related to

Sort By:
Pageof 118
European Journal of Preventive Cardiology|October 4, 2024
Cardiorespiratory Fitness in Childhood Cancer Survivors: A Systematic Review and Meta-AnalysisKaitlyn Weinkauf, Emma Fyfe, Dean Hewitt, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
<i>In Vitro</i> Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017Ian Morrissey, Stephen Hawser, Sibylle H Lob, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 8, 2022
Asymmetric Synthesis of Heterocyclic Chloroamines and Aziridines by Enantioselective Protonation of Catalytically Generated EnaminesLiam A McLean, Matthew W Ashford, James W B Fyfe, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 18, 2006
Expression and function of potassium channels in the human placental vasculatureMark Wareing, Xilian Bai, Fella Seghier, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibioticTrudy H Grossman, Agata L Starosta, Corey Fyfe, et al.
Investigational New Drugs|May 1, 1993
Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinomaR M Bukowski, J Young, G Goodman, et al.
Virology|March 12, 2002
Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapyJoseph Torresi, Linda Earnest-Silveira, Georgia Deliyannis, et al.
Thrombosis and Haemostasis|July 1, 1997
Tissue factor in the pathogenesis of atherosclerosisM B Taubman, J T Fallon, A D Schecter, et al.
Gut|February 24, 2007
Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori statusSvein Hansen, Stein Emil Vollset, Mohammad H Derakhshan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
A phase I and pharmacokinetic study of ixabepilone in combination with Carboplatin in patients with advanced solid malignanciesRuth Plummer, Penella Woll, David Fyfe, et al.
Pageof 118